Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Political Experts (outside Washington DC)

Council Members in this Study Group: 711

This study group may include professors, attorneys, former regulatory officers, and consultants knowledgeable on topics such as law and litigation issues, lobbying, policy and government, elections, antitrust, immigration, intellectual property, and legislation, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Paul Equale, President, EQUALE AND ASSOCIATESPaul Equale

President
EQUALE AND ASSOCIATES
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Paul Equale leads Equale & Associates, where he consults on legislative, regulatory and headline risk associated with business, legal and financial services issues in Washington DC. His specialty areas include financial services legislative and regulatory...

Richard Tarplin

Principal
Tarplin Strategies, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Richard Tarplin is the founder of Tarplin Strategies in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and health care sectors. He served for almost 20 years in the US House of Representatives...

Jeff Stier, Associate Director, American Council on Science and HealthJeff Stier

Associate Director
American Council on Science and Health
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Jeff Stier is an Associate Director at the American Council on Science and Health, a public health and consumer advocacy organization dedicated to promoting sound science in public health. In this position, he is responsible for government relations,...

Deborah Outlaw, Principal, THE OUTLAW GROUPDeborah Outlaw

Principal
THE OUTLAW GROUP
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Deborah Outlaw is the Principal of The Outlaw Group in Washington, DC, where she provides legislative and regulatory services to physician specialty groups, allied health providers, medical device manufacturers, and non-profit organizations interested...

Robert Strong

Partner
CLARK HILL PLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert A.W. Strong is Partner at Clark Hill in Birmingham, Michigan, where he has represented industrial clients in all areas of energy and utility law, including contracting, rate negotiation, ratemaking, environmental permitting, energy pricing and...

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Black Box Warnings: Not Blacklist Warnings

August 6, 2009

UPDATE: FDA: Requires Stronger Warnings For TNF Blocker Drugs | online.wsj.com

The risk highlighted by this new bold warning was a known risk. The questions are: How should physicians and patients respond to a new warning rather than new risks? What are the risks of black box warnings?What are the implications for Johnson & Johnson (JNJ), which makes Remicade and Simponi, Abbott (ABT), maker of Humira and Amgen (AMGN) and Wyeth (WYE), co-marketers of Enbrel, as well as UCB SA's (UCB.BT) maker of Cimzia?

FDA Warning On E-Cigs is Tone Deaf

July 22, 2009

FDA Questions Safety, Quality of Electronic Cigarettes | blogs.wsj.com

Even major tobacco companies are now considering E-cigarettes, but the FDA is dead set against them. This is a harbinger of how FDA will use their new authority to regulate tobacco.

Swine Flu Presents Opportunities for Vaccine Makers And Others

July 21, 2009

Financial Times FT.com | www.ft.com

A relatively small group of pharmaceutical companies includingGlaxoSmithKline, Roche and Sanofi-Aventis  which make vaccines have the market cornered when it comes to the front lines of the global fight against swine flu. But well positioned smaller companies could benefit

Sometimes, Breast Cancer Legislation Could Do More Harm Than Good

July 14, 2009

Detecting a Bad Breast Cancer Bill | www.rollcall.com

New legislation calls for more widespread genetic testing for breast cancer as well as other types of breast cancer screening.     

Potential Good News for Biosimilars

July 14, 2009

US Senate panel backs 12-year biotech drug shelter | www.reuters.com

This is good news for Amgen Inc (AMGN.O) and Roche Holding AG (ROG.VX) as longer exclusivity passes a major Senate hurdle.     While some are calling this a defeat for "generic" (biosimilar) makers such as Teva Pharmaceutical Industries Ltd (TEVA.TA) and Mylan Inc (MYL.O), it isn't all bad news.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Institution*
  • Lobbying Firm
  • Policy or Political Consulting Firm
  • Law Firm (general practice/large)
  • Think Tank
  • Advocacy Group or Issue Focused
  • Professional or Industry Association*
  • Law Firm (Boutique / Specialized)
  • State Government

Members in this Study Group often have these job titles:

  • Professor
  • Assistant Professor
  • Director
  • Partner
  • Lobbyist
  • Principal
  • President

GLG Live Meetings with this Study Group's Leading Experts (?)

September 20, 2006 | Boston

GLGi: CMS Reimbursements: Medical Devices

September 19, 2006 | New York City

GLGi: CMS Reimbursements: Medical Devices

December 6, 2005 | New York

GLGi: Terrorism Risk Insurance Act

GLG Webcasts & Teleconferences

Leading Experts in Political Experts (outside Washington DC) have not participated in any GLG webcasts.

View All GLG Webcasts & Teleconferences in Legal, Economic & Regulatory Affairs